Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
24187
CAS Number:
71119-11-4, 70369-47-0
Bucindolol
Purity:
≥ 98% (HPLC)
Synonym(s):
2-[2-hydroxy-3-[[2-(1 H -indol-3-yl)-1,1-diméthyléthyl]amino]propoxy]benzonitrile
Documents
$310.00 /250 mg
Taille
Request Bulk Quote
Product Information

Bucindolol is a unique beta-blocker that has garnered attention for its potential applications in cardiovascular medicine. This compound is recognized for its dual action, functioning as both a beta-adrenergic antagonist and a partial agonist, which allows it to effectively manage hypertension and heart failure. Bucindolol's ability to improve cardiac function while minimizing adverse effects makes it an attractive option for patients requiring long-term management of heart conditions. Its distinctive structure, featuring a hydroxyl group and an indole moiety, contributes to its pharmacological profile, enhancing its efficacy in clinical settings.

In research and pharmaceutical development, Bucindolol has been explored for its potential benefits in treating various cardiovascular disorders, including arrhythmias and ischemic heart disease. Its unique properties allow for a tailored approach in therapy, providing healthcare professionals with a versatile tool in managing complex patient profiles. Bucindolol's favorable safety profile and effectiveness in reducing heart rate and blood pressure make it a valuable asset in both clinical and research environments, paving the way for innovative treatment strategies in cardiovascular health.

Synonyms
2-[2-hydroxy-3-[[2-(1 H -indol-3-yl)-1,1-diméthyléthyl]amino]propoxy]benzonitrile
CAS Number
71119-11-4, 70369-47-0
Purity
≥ 98% (HPLC)
Molecular Formula
C22H25N3O2
Molecular Weight
363.46
MDL Number
MFCD00865898
PubChem ID
51044
Appearance
White solid
Conditions
Conserver à 0-8°C
General Information
Synonyms
2-[2-hydroxy-3-[[2-(1 H -indol-3-yl)-1,1-diméthyléthyl]amino]propoxy]benzonitrile
CAS Number
71119-11-4, 70369-47-0
Purity
≥ 98% (HPLC)
Molecular Formula
C22H25N3O2
Molecular Weight
363.46
MDL Number
MFCD00865898
PubChem ID
51044
Appearance
White solid
Conditions
Conserver à 0-8°C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

Bucindolol is widely utilized in research focused on

  • Cardiovascular Medicine: Primarily used as a beta-blocker, Bucindolol helps manage hypertension and heart failure, providing significant benefits in reducing heart rate and blood pressure.
  • Pharmacogenomics: Researchers study Bucindolol's efficacy in different populations, particularly in relation to genetic variations that affect drug metabolism, enhancing personalized medicine approaches.
  • Clinical Trials: It is often involved in clinical studies to evaluate its effectiveness compared to other beta-blockers, helping to establish best practices in treatment protocols.
  • Combination Therapies: Bucindolol is explored in combination with other medications to improve outcomes in patients with complex cardiovascular conditions, offering a multifaceted approach to treatment.
  • Research on Side Effects: Ongoing studies assess Bucindolol's side effect profile, contributing to safer prescribing practices and better patient management in clinical settings.

Citations